跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 249 条关于
“VITT”
全部
249
临床试验
193
药物
16
机构
9
资讯
31
7个月前
Researchers Identify Genetic Mechanism Behind Rare Blood Clotting in Johnson & Johnson and AstraZeneca COVID Vaccines
10个月前
Immunic's Vidofludimus Calcium Shows Promising MS Data as Phase 3 Trials Approach 2026 Readout
去年
Immunic's Vidofludimus Calcium Shows Promise in Multiple Sclerosis Treatment
7个月前
Immunic Raises $400M to Advance First-in-Class Multiple Sclerosis Therapy Toward Commercial Launch
去年
Immunic Secures Fifth US Patent for Multiple Sclerosis Drug Vidofludimus Calcium, Extending Protection Through 2041
去年
Immunic's IMU-856 Shows Promise in GLP-1 Elevation and Weight Management Potential
2年前
Immunic's Vidofludimus Calcium Enters Phase 2 Trial for Post-COVID Syndrome
8个月前
Immunic Completes Phase 3 Enrollment for Multiple Sclerosis Drug, Reports Positive Progressive MS Data
去年
Immunic's Vidofludimus Calcium Phase 3 Trials for Relapsing MS to Continue Unchanged After Positive Interim Analysis
去年
Immunic's IMU-856 Shows Promise in Celiac Disease Treatment by Restoring Gut Health
第 1 页,共 4 页
上一页
下一页